MetaBiom
Microbiome & Chronic Diseases

Evidence Based Medicine
Sign in

Blautia wexlerae ⇒ Blautia {10001360}

Record Keys


Organism:
Blautia wexlerae
Parent:

Details


Initialisation date:[  ]

Meta Information


Rank:
Species
Domain:
Bacteria
Zone:[  ]
Enzyme:[  ]
Function:[  ]

Notes:


[  ]

References Notes


[  ]

Shared Reference Notes


  • [1.5
    - The abundances of Blautia wexlerae were linked to high blood levels of metabolites associated with several chronic diseases.
  • [1.1] [#Diabetes Type 2] [#Oral administration of Blautia wexlerae
    - Blautia genus, especially B. wexlerae, as a commensal bacterium that is inversely correlated with #Obesity and type 2 diabetes mellitus. - Oral administration of B. wexlerae to mice induce metabolic changes and anti-inflammatory effects that decrease both high-fat diet–induced #Obesity and diabetes. - The beneficial effects of B. wexlerae are correlated with unique amino-acid metabolism to produce S-adenosylmethionine, acetylcholine, and L-ornithine and carbohydrate metabolism resulting in the accumulation of amylopectin and production of succinate, lactate, and acetate, with simultaneous modification of the gut bacterial composition. - S-adenosylmethionine, acetylcholine, and L-ornithine have anti-inflammatory properties and modify aspects of host metabolism, such as lipid metabolism, indicating that these compounds are potential effector metabolites for controlling #Obesity and diabetes.